Modulation of Effector Caspase Cleavage Determines Response of Breast and Lung Tumor Cell Lines to Chemotherapy

REFERENCES

• Parkin D. M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55(2)74–108
   PubMed Web of Science ®Google Scholar
• Yoh K., Ishii G., Yokose T., Minegishi Y., Tsuta K., Goto K., Nishiwaki Y., Kodama T., Suga M., Ochiai A. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin. Cancer Res. 2004; 10(5)1691–1697
   PubMed Web of Science ®Google Scholar
• Gee M. S., Upadhyay R., Bergquist H., Weissleder R., Josephson L., Mahmood U. Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment. Int. J. Cancer 2007; 121(11)2492–2500
   PubMed Web of Science ®Google Scholar
• Janssen K., Pohlmann S., Janicke R. U., Schulze-Osthoff K., Fischer U. Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood 2007; 110(10)3662–3672
   PubMed Web of Science ®Google Scholar
• Wieder T., Essmann F., Prokop A., Schmelz K., Schulze-Osthoff K., Beyaert R., Dorken B., Daniel P. T. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 2001; 97(5)1378–1387
   PubMed Web of Science ®Google Scholar
• Thornberry N. A. Caspases: key mediators of apoptosis. Chem. Biol 1998; 5(5)R97–103
   PubMed Web of Science ®Google Scholar
• Dlamini Z., Mbita Z., Ledwaba T. Can targeting apoptosis resolve the cancer saga?. Future Oncol. 2005; 1(3)339–349
   PubMedGoogle Scholar
• Green D. R., Evan G. I. A matter of life and death. Cancer Cell. 2002; 1(1)19–30
   PubMed Web of Science ®Google Scholar
• Lu X., Arthur G. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res. 1992; 52(10)2813–2817
   PubMed Web of Science ®Google Scholar
• Duan W. R., Garner D. S., Williams S. D., Funckes-Shippy C. L., Spath I. S., Blomme E. A. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 2003; 199(2)221–228
   PubMed Web of Science ®Google Scholar
• Sanghavi D. M., Thelen M., Thornberry N. A., Casciola-Rosen L., Rosen A. Caspase-mediated proteolysis during apoptosis: insights from apoptotic neutrophils. FEBS Lett. 1998; 422(2)179–184
   PubMed Web of Science ®Google Scholar
• Achilefu S., Bloch S., Markiewicz M. A., Zhong T., Ye Y., Dorshow R. B., Chance B., Liang K. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc. Natl. Acad. Sci. USA 2005; 102(22)7976–7981
   PubMed Web of Science ®Google Scholar
• Coxon J. P., Oades G. M., Kirby R. S., Colston K. W. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation. BJU Int. 2004; 94(1)164–170
   PubMed Web of Science ®Google Scholar
• Hiraga T., Williams P. J., Ueda A., Tamura D., Yoneda T. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin. Cancer Res. 2004; 10(13)4559–4567
   PubMed Web of Science ®Google Scholar
• Zeng H., Wei Q., Huang R., Chen N., Dong Q., Yang Y., Zhou Q. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter. J. Androl. 2007; 28(6)827–835
   PubMed Web of Science ®Google Scholar
• Zeng Z., Yuan X., Liu G., Zeng X., Zeng X., Ng H., Chen H., Jiang T., Akasaki Y., Kessey K., Black K. L., Yu J. S. Manipulation of proliferation and differentiation of human bone marrow-derived neural stem cells in vitro and in vivo. J. Neurosci. Res. 2007; 85(2)310–320
   PubMed Web of Science ®Google Scholar
• Kerr L. E., Birse-Archbold J. L., Simon A., Logan N., Scott F., Carlson G., Nicholson D. W., Kelly J. S., Sharkey J. Differential regulation of caspase-3 by pharmacological and developmental stimuli as demonstrated using humanised caspase-3 mice. Apoptosis 2004; 9(6)739–747
   PubMed Web of Science ®Google Scholar
• Li R., Moudgil T., Ross H. J., Hu H. M. Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell. Death Differ. 2005; 12(3)292–303
   PubMed Web of Science ®Google Scholar
• Liebmann J. E., Cook J. A., Lipschultz C., Teague D., Fisher J., Mitchell J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br. J. Cancer 1993; 68(6)1104–1109
   PubMed Web of Science ®Google Scholar
• Rossi D., Gaidano G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 2003; 88(2)212–218
   PubMedGoogle Scholar
• Perkins C., Kim C. N., Fang G., Bhalla K. N. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res. 1998; 58(20)4561–4566
   PubMed Web of Science ®Google Scholar
• Perkins C. L., Fang G., Kim C. N., Bhalla K. N. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 2000; 60(6)1645–1653
   PubMed Web of Science ®Google Scholar
• Ponnathpur V., Ibrado A. M., Reed J. C., Ray S., Huang Y., Self S., Bullock G., Nawabi A., Bhalla K. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Clin. Cancer Res. 1995; 1(11)1399–1406
   PubMed Web of Science ®Google Scholar
• Schiff P. B., Horwitz S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 1980; 77(3)1561–1565
   PubMed Web of Science ®Google Scholar
• Schiller J.H., Harrington D., Belani C. P., Langer C., Sandler A., Krook J., Zhu J., Johnson D. H. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 2002; 346(2)92–98
   PubMed Web of Science ®Google Scholar
• Parkin D. M., Bray F. I., Devesa S. S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 2001; 37(Suppl 8)S4–S66
   PubMed Web of Science ®Google Scholar
• Goncalves A., Braguer D., Kamath K., Martello L., Briand C., Horwitz S., Wilson L., Jordan M. A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. USA 2001; 98(20)11737–11742
   PubMed Web of Science ®Google Scholar
• Hei T. K., Hall E. J. Taxol, radiation, and oncogenic transformation. Cancer Res. 1993; 53(6)1368–1372
   PubMed Web of Science ®Google Scholar
• McCloskey D. E., Armstrong D. K., Jackisch C., Davidson N. E. Programmed cell death in human breast cancer cells. Recent Prog. Horm. Res. 1996; 51: 493–508
   PubMedGoogle Scholar
• Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376(6535)37–43
   PubMed Web of Science ®Google Scholar
• Park S. J., Wu C. H., Gordon J. D., Zhong X., Emami A., Safa A. R. Taxol induces caspase-10-dependent apoptosis. J. Biol. Chem. 2004; 279(49)51057–51067
   PubMed Web of Science ®Google Scholar
• Weigel T. L., Lotze M. T., Kim P. K., Amoscato A. A., Luketich J. D., Odoux C. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity. J. Thorac. Cardiovasc. Surg. 2000; 119(4 Pt 1)795–803
   PubMed Web of Science ®Google Scholar
• Broker L. E., Huisman C., Span S. W., Rodriguez J. A., Kruyt F. A., Giaccone G., Cathepsin B. mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 2004; 64(1)27–30
   PubMed Web of Science ®Google Scholar
• Huisman C., Ferreira C. G., Broker L. E., Rodriguez J. A., Smit E. F., Postmus P. E., Kruyt F. A., Giaccone G. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin. Cancer Res. 2002; 8(2)596–606
   PubMed Web of Science ®Google Scholar
• Soung Y. H., Lee J. W., Kim S. Y., Park W. S., Nam S. W., Lee J. Y., Yoo N. J., Lee S. H. Somatic mutations of CASP3 gene in human cancers. Hum. Genet. 2004; 115(2)112–115
   PubMed Web of Science ®Google Scholar